U.S. Markets close in 5 hrs 5 mins

Novartis Joins Pfizer in Holding Line on Drug Prices in U.S.

James Paton
Novartis Joins Pfizer in Holding Line on Drug Prices in U.S.

Swiss drugmaker Novartis AG is holding the line on U.S. prices this year as an attack from President Donald Trump led rival Pfizer Inc. to delay planned increases for some medicines. Novartis has voluntarily pulled back on increasing prices in the U.S., Chief Executive Officer Vas Narasimhan said on a call Wednesday.